Clinical trials · New York, NY
Obesity clinical trials in New York
We’re tracking 78 recruiting obesity studies with a site in or near New York — including Phase 1, Phase 2, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies near New York
- NCT06760546RecruitingPhase 3
Testing setmelanotide for weight gain after brain injury
This trial tests a daily injection called setmelanotide to see if it can help people who have gained weight due to a brain injury or condition affecting the hypothalamus. It may help reduce hunger and support weight loss.
New York, New YorkAges 4 years+ - NCT04101669Recruiting
Diabetes device trial to improve blood sugar and weight
This study tests the RESET System to help people with type 2 diabetes lower their average blood sugar (HbA1c) despite current medication. It may also affect weight and safety outcomes by changing how food moves through the gut.
New York, New YorkAges 22–65 - NCT05770570RecruitingPhase 2
Diet and activity texting support for Mexican American drivers
This Phase 2 study tests a structured program using texts and recordings to help people improve diet and physical activity for weight loss. It focuses on specific Spanish-speaking groups and also includes a separate track for taxi/FHV drivers.
New York, New YorkAges 21 years+ - NCT07446998RecruitingPhase 2
Study on enobosarm for weight loss in older adults on semaglutide
This trial tests if adding enobosarm (a muscle-preserving drug) to semaglutide (a weight-loss medication) can help older adults maintain muscle and improve physical function while losing weight. It may be an option for people who are already taking semaglutide and want to prevent muscle loss.
New York, New YorkAges 65–100 - NCT04494048Recruiting
Registry for people considering endoscopic weight-loss procedures
This study keeps a record of people who are planning or recently had an endoscopic (camera-based) weight-loss procedure. The goal is to learn how these procedures work in real life and help doctors improve care.
New York, New YorkAges 18–89 - NCT01998750Recruiting
Study of genes in severe early childhood obesity
This study looks for genetic (inherited) reasons for severe obesity that starts in very early childhood. It may help doctors better understand the cause of your child’s weight gain and guide future treatment.
New York, New YorkAges Up to 80 years - NCT05935592Recruiting
Family phone tool to help kids at risk for weight gain
This study tests an interactive phone/tablet program for children and their parent or guardian, aiming to reduce the child’s risk of unhealthy weight gain. It may help by giving family-focused tips and support you can use at home.
New York, New YorkAges 8–12 - NCT06329544Recruiting
Study of a high-fructose diet and gut health
This trial tests how a high-fructose diet affects your gut bacteria and overall metabolic health. It is for people who already know they don't absorb fructose well (fructose malabsorbers) and want to understand how this sugar impacts their body.
New York, New YorkAges 25–45 - NCT06592261RecruitingPhase 1
Insulin suppression test for weight groups
This study tests a new way to measure how the body handles insulin in people with different body weights. It may help researchers understand insulin resistance better.
New York, New YorkAges 18–65 - NCT06853288Recruiting
How processed foods affect energy from food
This study looks at how eating ultra-processed foods changes how much energy your body takes from food. If you have a BMI between 30 and 40 and are otherwise healthy, you may help scientists learn more about weight and metabolism.
New York, New YorkAges 25 years+ - NCT07037459RecruitingPhase 3
A study of a new drug for heart failure with obesity
This trial tests a medication called maridebart cafraglutide for people with heart failure (where the heart doesn't pump as well as it should) and obesity. The goal is to see if it can help improve symptoms and outcomes.
New York, New YorkAges 18–99 - NCT07339423RecruitingPhase 3
A study of a new medicine for weight loss
This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.
New York, New YorkAges 18 years+ - NCT06335810Recruiting
Reducing obesity with a buddy program
This study explores whether having a friend or family member join you in a weight-loss program helps reduce obesity. You and your buddy will use a food-tracking app and get support from the program.
New York, New YorkAges 18 years+ - NCT07090005Recruiting
Endoscopic weight loss: comparing EndoZip and Apollo ESG
This study compares two different endoscopic procedures (EndoZip and Apollo ESG) to help obese patients lose weight. Both are done through the mouth without cutting the skin, and the goal is to see which works better and is safer.
New York, New YorkAges 21–65 - NCT02602769Recruiting
Testing blood traits in children with ROHHAD syndrome
This trial studies children with ROHHAD syndrome to better understand their body chemistry and other blood features. The results may help researchers learn what drives the condition and how it might be tracked over time.
New York, New YorkAges 2–20 - NCT06899178RecruitingPhase 2
Atomoxetine for genetic obesity due to MC4R changes
This trial tests a medicine called atomoxetine (Strattera) to help people with a specific genetic form of obesity lose weight. It may be an option if you have a change in the MC4R gene and have not used certain other medications recently.
New York, New YorkAges 6 years+ - NCT05919797RecruitingPhase 4
Weight loss genetics study with naltrexone and bupropion
This trial studies how your genetic makeup and body response may affect weight loss with a medication combination called naltrexone and bupropion. If you qualify, you’ll likely take these medicines and be monitored for safety and changes in weight over time.
New York, New YorkAges 18–65 - NCT07156578Enrolling by invitationPhase 2
Long-term bivamelagon for hypothalamic obesity
This long-term study tests a new drug, bivamelagon, for people with hypothalamic obesity. It's for those who already completed a similar study and tolerated the drug well.
New York, New YorkAges 12 years+ - NCT07554638RecruitingPhase 4
Incretin drugs for heart failure with obesity
This trial tests whether incretin-based diabetes medications (like GLP-1 drugs) can help people with a specific type of heart failure called HFpEF that is linked to obesity. The goal is to see if these drugs improve heart function and symptoms.
New York, New YorkAges 40 years+ - NCT07353931RecruitingPhase 3
Study of eloralintide for knee osteoarthritis pain in people with overweight or obesity
This trial tests an investigational drug called eloralintide to see if it can reduce knee pain in people with osteoarthritis who also have overweight or obesity. You may be able to join if you have knee osteoarthritis, a BMI of 27 or higher, and have tried to lose weight with diet before.
Long Island City, New YorkAges 18 years+ - NCT07282600RecruitingPhase 3
Study of eloralintide for type 2 diabetes and weight
This study tests a new medicine called eloralintide for people with type 2 diabetes who are overweight or have obesity. It aims to see if the drug can help with weight loss and blood sugar control.
Long Island City, New YorkAges 18 years+ - NCT07667803RecruitingPhase 3
Study of elecoglipron for weight loss in obesity or overweight
This trial tests an investigational drug called elecoglipron to see if it helps people with obesity or overweight lose weight. It may be an option if you have a high body mass index or weight-related health issues like high blood pressure or prediabetes.
Long Island City, New YorkAges 18 years+ - NCT07784725RecruitingPhase 3
Study of a weight loss injection for adults with obesity
This study tests a new medicine to help adults with obesity or overweight lose weight. It's for people who have had trouble losing weight in the past and don't have diabetes.
Jersey City, New JerseyAges 18 years+ - NCT07743450RecruitingPhase 3
Once-daily pill for weight loss in people with type 2 diabetes
This study tests an oral medication, ASC30, to see if it helps people with type 2 diabetes who are overweight or obese lose weight and improve blood sugar control. It is a once-daily pill that may offer a new treatment option.
Jersey City, New JerseyAges 18 years+
Hear when a new Obesity trial opens near New York, NY
We’ll email you when one opens near New York, NY — at most once a week, no account needed, unsubscribe anytime.
Obesity trials in other cities
Where these studies are running near New York
Institutions with a site for the recruiting obesity studies listed above.
- Columbia University Irving Medical Center · 8 studies
- Weill Cornell Medicine · 3 studies
- NYC Research INC · 2 studies
- Research Site · 2 studies
- Advanced Heart Care, LLC
- ALSA Research
- AURORA Clinical Sites
- AURORA-2 Clinical Site
What taking part in a obesity study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting obesity studies in New York.
Common questions
- Are there obesity clinical trials near New York?
- Yes. We're currently tracking 78 recruiting obesity studies with a site near New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a obesity study near New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site near New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a obesity trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New obesity studies open near New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.